Compounds > n-formylmethionine leucyl-phenylalanine

n-formylmethionine leucyl-phenylalanine and Hematologic Malignancies

n-formylmethionine leucyl-phenylalanine has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fruehauf, S; Haas, R; Murea, S; Zeller, WJ1

Other Studies

1 other study(ies) available for n-formylmethionine leucyl-phenylalanine and Hematologic Malignancies

ArticleYear
Granulocytes harvested following G-CSF-enhanced leukocyte recovery retain their functional capacity during in vitro culture for 72 hours.
    Journal of hematotherapy, 1996, Volume: 5, Issue:4

    Topics: Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Blood Preservation; Blood Transfusion, Autologous; Cell Adhesion; Cell Survival; Cells, Cultured; Cryopreservation; Filgrastim; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematologic Neoplasms; Humans; Immunophenotyping; Leukapheresis; Leukocyte Transfusion; N-Formylmethionine Leucyl-Phenylalanine; Neutropenia; Phagocytosis; Receptors, Immunologic; Recombinant Proteins; Respiratory Burst; Superoxides; Tetradecanoylphorbol Acetate

1996